期刊文献+

HBV-DNA水平与HBIG母婴阻断效果影响因素分析

Impact of HBV-DNA levels on the blocking of transmission of hepatitis B from mothers to babies by injection of hepatitis B immunoglobulin
原文传递
导出
摘要 目的探讨HBV-DNA水平对HBIG母婴阻断效果的影响,研究提高阻断成功率的有效方法。方法将乙肝携带产妇和婴儿应用HBIG的情况按照HBV-DNA水平分层,分析HBIG不同使用方法和使用时机对阻断成功率的影响。结果儿童出生后乙肝球蛋白注射2针次与1针次的阻断成功率没有差别;HBV-DNA阳性的孕妇产前多次注射乙肝球蛋白可以提高阻断成功率。分娩方式、婴儿喂养方式对阻断成功率没有影响。结论 HBV-DNA阳性孕妇产前注射乙肝球蛋白3针次的阻断效果好,HBV-DNA阴性孕妇产前可以不注射乙肝球蛋白,而只在儿童出生后注射乙肝球蛋白,阻断效果即可达到最佳。自然分娩和母乳喂养对婴儿是安全的,不增加乙肝感染率。儿童出生后乙肝球蛋白注射1针次就可达到效果。 Aim To investigate the impact of HBV-DNA levels on the blocking of transmsstion of hepatitis B from mothers to the babies by injection of hepatitis B immunoglobulin (HBIG). Methods Hepatitis B carrying mothers and infants injected with HBIG were investigated. Results There no significant differences were observed in infants given one to two injections of hepatitis B immunoglobulin for blocking transmssion of hepatitis B. The rate for successful blocking of heptitis B transmission from mothers to the babies could be enhanced by several injection of HBIG in HBV-DNA positive mothers before delivery. While no significant impact of delivery and feeding ways on the blocking rate was observed. Conclusions Antinatal one,two or three injection of HBIG in HBV-DNA positive pregnant women can blocking the transmission of hepatitis B,and the effect of protection of infants from infection of hepatitis B can be achived by one injection of HBIG in infants after birth.
出处 《中国热带医学》 CAS 2010年第12期1451-1452,1455,共3页 China Tropical Medicine
关键词 乙肝 母婴垂直传播 人乙肝免疫球蛋白 HBV-DNA Hepatitis B Vertical Transmission Human hepatitis B immunoglobulin HBV-DNA
  • 相关文献

参考文献5

二级参考文献19

  • 1冯晴,杨瑞冬,甄翠芬,李为.母亲感染乙肝病毒婴儿喂养方式的探讨[J].大理医学院学报,2001,10(3):58-60. 被引量:2
  • 2李祥芳,吴萍.孕妇免疫预防新生儿破伤风[J].中华妇产科杂志,1993,28(2):107-108. 被引量:11
  • 3牟瑞丽,马玉燕,李桦,孔北华,江森.乙型肝炎病毒携带者母乳喂养的研究[J].中华围产医学杂志,2005,8(1):20-23. 被引量:26
  • 4朱启镕,吕晴,顾新焕,段恕诚,徐华芳,张秀珍,董左叔.阻断乙型肝炎病毒宫内传播的初步研究[J].中华儿科杂志,1995,33(2):93-95. 被引量:107
  • 5高寿征.病毒性肝炎防治研究[M].北京:北京出版社,1994.266.
  • 6Chen DS,Hsu HM,Bennet CL,et al.A program for eradication of hepatitis B from Taiwan by a 10-year,four-dose vaccination program.Cancer Cause Control, 1996,7(3):305-311
  • 7Mcmahon BJ, Bulow L, Harpstera et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a16 year population based study. Hepatology, 2000, 32 (4 pt 1): 842 ~846.
  • 8Yu MW, Chang HC, Liaw YF et al. Faminial risk of hepatocelluar carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst, 2000, 92 (14): 1159 ~ 1164.
  • 9Tang JR, Hsu HY, Lin HH et al. Hepatitis B surface antigenemia at birth: a long-term follow up study. J Pediatre, 1998, 133 (3): 374 ~377.
  • 10Bertoletti A, Maini MK. Protection or damage: a dual role for the virus specific cytotoxin T lymphocyte response in hepatitis B and C infection?Curr Opin Microbiol, 2000, 3 (4): 387~392.

共引文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部